SEC
Filings

Menu

Tabs Financials

SEC Filings

Filing date Form Description Filing Group View
CORRESP

CORRESP

Other
View HTML
S-4/A

Pre-effective amendment to an S-4 filing

Registration Statements
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
CORRESP

CORRESP

Other
View HTML
UPLOAD

UPLOAD

Other
View HTML
SC 13D/A

An amendment to a SC 13D filing

Other
View HTML
CORRESP

CORRESP

Other
View HTML
425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
UPLOAD

UPLOAD

Other
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML

Data provided by Kaleidoscope.

 

Investor Contact

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe